Impaired cell-mediated immunity in patients with classic hemophilia.
Impaired cell-mediated immunity in patients with classic hemophilia.
复制标题
典型血友病患者细胞介导的免疫力受损。
DOI:
10.1056/nejm198301133080205
复制
发表时间:
1983
期刊:
影响因子:
--
通讯作者:
Schacter,B
中科院分区:
文献类型:
--
作者:
Lederman,MM;Ratnoff,OD;Scillian,JJ;Jones,PK;Schacter,B
Patients with haemophilia treated with commercial lyophilized factor VIII concentrates are now being recognized as at risk of developing a clinical disease with features of acquired immune deficiency syndrome (AIDS).Pneumocystis cariniipneumonia, a relative decrease of helper T lymphocytes (T4) and an increase in suppressor T cells have been described in this group. These observations prompted an investigation of 19 healthy patients with haemophilia and 19 healthy age-matched control subjects. Of the former group 11 had received lyophilized factor VIII concentrates within the previous year ranging from 3 to 200 infusions (median 30-36)-LYOPH group; 4 of the remaining 8 had received cryoprecipitate (1 supplemented on 2 occasions with concentrate) and 4 had received no therapy in the preceding 20 months-CRYO group. When compared with control subjects the LYOPH group had a relative decrease in helper T cells, a relative and absolute increase of suppressor T cells and depressed helper/suppressor ratios. However, it appears that patients with haemophilia had only a relative decrease of helper T4 cells as compared with patients with AIDS who are more likely to have an absolute decrease in T4 cells. The LYOPH group also showed a reduction in natural-killer cell activity and decreased proliferative responses to mitogens. Lymphocyte counts and surface markers in the CRYO group were similar to those in the control group. The available evidence seems to incriminate some agent in lyophilized factor VIII concentrates. Hepatitis B virus was excluded as a cause. Further investigations are required into the nature of this putative agent.K.C. Watson